Saturday 9 September 5:59:00 AM CET/ Friday 8 September 11:59 PM (US Eastern Daylight Time UTC -4)


Call for Proposals – Deadline to submit is Friday, September 8th 11:59 PM (US Pacific Standard Time UTC -8)

Publication: Selected abstracts will be published on an electronic media for distribution at the meeting and will be available online.

Embargo Date: Wednesday, January 31st, 2018

Theme: Ischemia Imaging

Previous Presentation of Abstracts: Abstracts ARE NOT considered for presentation if they were either published as an article or previously presented at a national or international meeting prior to the date of this presentation. Please be aware that submitted abstracts will be checked for plagiarism against previously published abstracts and articles using automated software.

Conflict of Interest: If the research was partially or fully funded by a proprietary organization (e.g. pharmaceutical, biotech or device manufacture), you must describe the nature of the relationship. Example: “Research was funded in part by the XYZ Corporation, City, State.” Please do not list any authors with the disclosure text.

Grading: Abstracts are graded through a blind review. Authors should be cautious in using institutional references in the body of the abstracts. Do not put author names and affiliations in the body portion of the abstract.

Submission: When you have completed your online abstract form, click on Submit Abstract, but ONLY when you are sure that your abstract is complete and in final form.

Changes to Abstract after Submission: The EuroCMR/SCMR is not authorized to make changes to a submission. In order to correct your abstract, you must withdraw it and submit a new corrected version prior to the deadline by September 8, 2017, 11:59 PM, PST (See below for withdrawal procedure). Note that, such replacement of your abstract is not possible after the deadline Please carefully proofread abstracts to avoid errors before submission. If accepted, your abstract will be published EXACTLY as it was submitted.

Abstract Receipt Confirmation: If you submit on or before the deadline date, you will receive an email confirmation within two business days of submitting your abstract. If you submit on the deadline date and do not receive a confirmation within 48 hours, please contact programme@cmr2018.

If you want to withdraw an abstract already submitted, please notify us as quickly as possible at stating the title and number of the abstract to be withdrawn.

Abstract Style: Remember that your abstract will appear EXACTLY as you submit it. Please check abstracts carefully for typographical errors, author listing, misspellings, poor hyphenation, etc. The will be glaringly apparent in the published abstracts.

Title: The title should be brief, but long enough to identify clearly the nature of the study.

Abstract Structure: The body of the abstracts should be organized as follows: 

  • Introduction: Briefly describe the objectives of the study unless they are contained in the title. Include a hypothesis.
  • Methods: A brief description of the methods used.
  • Results: Describe findings in sufficient detail to support conclusions.
  • Conclusions: A concise statement summarizing study and conclusions reached. 

Character and Word Count: There is a limit of 400 words (3,000 characters) for the text of your submission. The character count includes spaces. You will be advised of your character count usage throughout the submission process as you save and move to the next step. Your character and word count is displayed on the left hand side of your submission. The character count will not include title, authors, institutions, tables, and images.

Tables and Graphs: Simple tables and graphs may be included if they fit within the size constraints of the electronic program. Follow the instructions in the program for submitting graphs and use the table formatting function for table preparation.


  • Alternative contrast mechanisms
  • Contrast-enhanced perfusion imaging (Pulse sequences, Image artifacts, Accelerated imaging)
  • Coronary and microvascular hemodynamics
  • Experimental and clinical validation (Computational hemodynamics, Hybrid imaging, Preclinical validation studies, Clinical trials,)
  • Perfusion quantification